HRP20120344T1 - N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije - Google Patents
N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije Download PDFInfo
- Publication number
- HRP20120344T1 HRP20120344T1 HRP20120344TT HRP20120344T HRP20120344T1 HR P20120344 T1 HRP20120344 T1 HR P20120344T1 HR P20120344T T HRP20120344T T HR P20120344TT HR P20120344 T HRP20120344 T HR P20120344T HR P20120344 T1 HRP20120344 T1 HR P20120344T1
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- hydroxyethyl
- treatment
- compound according
- quinolin
- Prior art date
Links
- ZJKUETLEJYCOBO-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-methyl-4-[quinolin-8-yl-[1-(1,3-thiazol-4-ylmethyl)piperidin-4-ylidene]methyl]benzamide Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(C=1C2=NC=CC=C2C=CC=1)=C1CCN(CC=2N=CSC=2)CC1 ZJKUETLEJYCOBO-UHFFFAOYSA-N 0.000 title claims 5
- 208000019901 Anxiety disease Diseases 0.000 title claims 3
- 230000036506 anxiety Effects 0.000 title claims 3
- 238000000034 method Methods 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims abstract 15
- 239000003814 drug Substances 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- 208000020401 Depressive disease Diseases 0.000 claims 4
- 238000006243 chemical reaction Methods 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- UIUHRTMSQIPPSU-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-methyl-4-[piperidin-4-ylidene(quinolin-8-yl)methyl]benzamide Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(C=1C2=NC=CC=C2C=CC=1)=C1CCNCC1 UIUHRTMSQIPPSU-UHFFFAOYSA-N 0.000 claims 2
- KWSAVZDIBRTUEI-UHFFFAOYSA-N tert-butyl 4-[[4-[2-hydroxyethyl(methyl)carbamoyl]phenyl]-quinolin-8-ylmethylidene]piperidine-1-carboxylate Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(C=1C2=NC=CC=C2C=CC=1)=C1CCN(C(=O)OC(C)(C)C)CC1 KWSAVZDIBRTUEI-UHFFFAOYSA-N 0.000 claims 2
- LRCHQJMBFAIMEU-UHFFFAOYSA-N tert-butyl 4-[bromo-[4-[2-hydroxyethyl(methyl)carbamoyl]phenyl]methylidene]piperidine-1-carboxylate Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(Br)=C1CCN(C(=O)OC(C)(C)C)CC1 LRCHQJMBFAIMEU-UHFFFAOYSA-N 0.000 claims 2
- WRFKSVINLIQRKF-UHFFFAOYSA-N 1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC=N1 WRFKSVINLIQRKF-UHFFFAOYSA-N 0.000 claims 1
- ZXAPQWICZVMRRE-UHFFFAOYSA-N 4-[bromo-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-ylidene]methyl]benzoic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1=C(Br)C1=CC=C(C(O)=O)C=C1 ZXAPQWICZVMRRE-UHFFFAOYSA-N 0.000 claims 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 claims 1
- 206010029216 Nervousness Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 238000010511 deprotection reaction Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- KXJJSKYICDAICD-UHFFFAOYSA-N quinolin-8-ylboronic acid Chemical compound C1=CN=C2C(B(O)O)=CC=CC2=C1 KXJJSKYICDAICD-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- -1 quinolin-8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86232706P | 2006-10-20 | 2006-10-20 | |
| PCT/SE2007/000924 WO2008048171A1 (en) | 2006-10-20 | 2007-10-19 | N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120344T1 true HRP20120344T1 (hr) | 2012-05-31 |
Family
ID=39314285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120344TT HRP20120344T1 (hr) | 2006-10-20 | 2012-04-17 | N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7659286B2 (ru) |
| EP (1) | EP2079735B1 (ru) |
| JP (1) | JP4668346B2 (ru) |
| KR (1) | KR20090065534A (ru) |
| CN (1) | CN101528739B (ru) |
| AR (1) | AR063345A1 (ru) |
| AT (1) | ATE543818T1 (ru) |
| AU (2) | AU2007313515B2 (ru) |
| BR (1) | BRPI0717631A2 (ru) |
| CA (1) | CA2667041C (ru) |
| CL (1) | CL2007003009A1 (ru) |
| CO (1) | CO6180450A2 (ru) |
| CY (1) | CY1112718T1 (ru) |
| DK (1) | DK2079735T3 (ru) |
| ES (1) | ES2379519T3 (ru) |
| HK (1) | HK1131556A1 (ru) |
| HR (1) | HRP20120344T1 (ru) |
| IL (1) | IL197876A0 (ru) |
| MX (1) | MX2009003974A (ru) |
| MY (1) | MY148880A (ru) |
| NO (1) | NO20091969L (ru) |
| NZ (1) | NZ577060A (ru) |
| PE (2) | PE20080892A1 (ru) |
| PL (1) | PL2079735T3 (ru) |
| PT (1) | PT2079735E (ru) |
| RS (1) | RS52260B (ru) |
| RU (1) | RU2454414C2 (ru) |
| SA (1) | SA07280549B1 (ru) |
| SI (1) | SI2079735T1 (ru) |
| TW (1) | TW200826939A (ru) |
| UA (1) | UA97648C2 (ru) |
| UY (1) | UY30652A1 (ru) |
| WO (1) | WO2008048171A1 (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007503457A (ja) * | 2003-05-16 | 2007-02-22 | アストラゼネカ・アクチエボラーグ | ジアリールメチリデンピペリジン誘導体、その製造およびその使用 |
| MY148880A (en) | 2006-10-20 | 2013-06-14 | Astrazeneca Ab | N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression |
| NZ590041A (en) * | 2008-05-20 | 2012-11-30 | Astrazeneca Ab | Method of treating anxious major depressive disorder |
| CN101906078B (zh) * | 2009-06-08 | 2012-02-01 | 上海威智医药科技有限公司 | 噻唑衍生物的合成方法 |
| CN102106807B (zh) * | 2009-12-29 | 2013-03-27 | 上海中西制药有限公司 | 一种固体制剂的制备方法及所得固体制剂 |
| WO2020061165A1 (en) | 2018-09-21 | 2020-03-26 | Garland Industries, Inc. | Helical hardbanding |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2898339A (en) * | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| TW548271B (en) | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| AU2009799A (en) * | 1997-12-24 | 1999-07-19 | Ortho-Mcneil Pharmaceutical, Inc. | 4-(aryl(piperidin-4-yl)) aminobenzamides which bind to the delta-opioid receptor |
| US6492375B2 (en) * | 1998-06-30 | 2002-12-10 | Neuromed Technologies, Inc. | Partially saturated calcium channel blockers |
| SE9904673D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| JP2003518107A (ja) | 1999-12-20 | 2003-06-03 | ニューロメド テクノロジーズ， インコーポレイテッド | 部分飽和カルシウムチャネルブロッカー |
| AU2001241676A1 (en) * | 2000-03-03 | 2001-09-17 | Ortho-Mcneil Pharmaceutical, Inc. | 3-(diarylmethylene)-8-azabicyclo(3.2.1)octane derivatives |
| SE0001208D0 (sv) * | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
| SE0101768D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
| US20040204404A1 (en) * | 2002-09-30 | 2004-10-14 | Robert Zelle | Human N-type calcium channel blockers |
| SE0300105D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof |
| SE0301445D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0301444D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0301441D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0301442D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations therof and uses thereof |
| JP2007503457A (ja) * | 2003-05-16 | 2007-02-22 | アストラゼネカ・アクチエボラーグ | ジアリールメチリデンピペリジン誘導体、その製造およびその使用 |
| SE0400025D0 (sv) * | 2004-01-09 | 2004-01-09 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| WO2005087742A1 (en) | 2004-03-08 | 2005-09-22 | Exelixis, Inc. | Metabolic kinase modulators and methods of use as pesticides |
| MY148880A (en) | 2006-10-20 | 2013-06-14 | Astrazeneca Ab | N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression |
-
2007
- 2007-10-09 MY MYPI20091593A patent/MY148880A/en unknown
- 2007-10-18 TW TW096139052A patent/TW200826939A/zh unknown
- 2007-10-19 SI SI200730905T patent/SI2079735T1/sl unknown
- 2007-10-19 MX MX2009003974A patent/MX2009003974A/es active IP Right Grant
- 2007-10-19 CL CL200703009A patent/CL2007003009A1/es unknown
- 2007-10-19 KR KR1020097007893A patent/KR20090065534A/ko not_active Application Discontinuation
- 2007-10-19 ES ES07835125T patent/ES2379519T3/es active Active
- 2007-10-19 AR ARP070104641A patent/AR063345A1/es not_active Application Discontinuation
- 2007-10-19 PT PT07835125T patent/PT2079735E/pt unknown
- 2007-10-19 WO PCT/SE2007/000924 patent/WO2008048171A1/en active Application Filing
- 2007-10-19 CA CA2667041A patent/CA2667041C/en not_active Expired - Fee Related
- 2007-10-19 US US11/875,014 patent/US7659286B2/en not_active Expired - Fee Related
- 2007-10-19 PL PL07835125T patent/PL2079735T3/pl unknown
- 2007-10-19 AT AT07835125T patent/ATE543818T1/de active
- 2007-10-19 EP EP07835125A patent/EP2079735B1/en active Active
- 2007-10-19 JP JP2009533278A patent/JP4668346B2/ja not_active Expired - Fee Related
- 2007-10-19 BR BRPI0717631-7A patent/BRPI0717631A2/pt not_active IP Right Cessation
- 2007-10-19 RS RS20120166A patent/RS52260B/en unknown
- 2007-10-19 UY UY30652A patent/UY30652A1/es not_active Application Discontinuation
- 2007-10-19 RU RU2009111337/04A patent/RU2454414C2/ru not_active IP Right Cessation
- 2007-10-19 AU AU2007313515A patent/AU2007313515B2/en not_active Ceased
- 2007-10-19 UA UAA200903085A patent/UA97648C2/ru unknown
- 2007-10-19 DK DK07835125.1T patent/DK2079735T3/da active
- 2007-10-19 PE PE2007001423A patent/PE20080892A1/es not_active Application Discontinuation
- 2007-10-19 NZ NZ577060A patent/NZ577060A/en not_active IP Right Cessation
- 2007-10-19 CN CN2007800390975A patent/CN101528739B/zh not_active Expired - Fee Related
- 2007-10-20 SA SA7280549A patent/SA07280549B1/ar unknown
-
2009
- 2009-03-26 IL IL197876A patent/IL197876A0/en unknown
- 2009-03-31 CO CO0903310009033100A patent/CO6180450A2/es not_active Application Discontinuation
- 2009-05-20 NO NO20091969A patent/NO20091969L/no not_active Application Discontinuation
- 2009-11-26 HK HK09111031.9A patent/HK1131556A1/xx not_active IP Right Cessation
- 2009-12-21 US US12/643,202 patent/US7977355B2/en not_active Expired - Fee Related
-
2010
- 2010-10-06 AU AU2010226996A patent/AU2010226996A1/en not_active Abandoned
-
2012
- 2012-04-17 HR HRP20120344TT patent/HRP20120344T1/hr unknown
- 2012-04-25 CY CY20121100389T patent/CY1112718T1/el unknown
- 2012-07-24 PE PE2012001060A patent/PE20140634A1/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120344T1 (hr) | N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije | |
| TW200745111A (en) | New compounds | |
| EA200970296A1 (ru) | Содержащие диариловый эфир соединения мочевины | |
| UA92181C2 (ru) | Производные пиримидина и их применение в терапии и в производстве лекарственного средства для предотвращения и/или лечения болезни альцгеймера | |
| BRPI0409109A (pt) | novos compostos | |
| ATE397605T1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| RS52256B (en) | THERAPEUTIC USES OF COMPOUNDS WITH COMBINED SERT, 5-HT3 AND 5-HT1A ACTIVITIES | |
| BRPI0514738A (pt) | derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos | |
| NO20090328L (no) | Nye forbindelser 385 | |
| ATE440833T1 (de) | Antithrombotische diamide | |
| ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| TW200606164A (en) | New compounds | |
| BR112014006763A2 (pt) | n-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexa-hidro-ciclopenta[e][1,3]oxazin-4-il)-fenil)-amidas como inibidores de bace1 | |
| RU2008129723A (ru) | Ингибиторы ccr9 активности | |
| RS51485B (en) | USE OF AGOMELATIN FOR OBTAINING MEDICINES INTENDED FOR TREATMENT OF GENERALIZED ANXIETY DISORDER | |
| SE0100569D0 (sv) | New compounds | |
| TW200800984A (en) | New compounds | |
| TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
| DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
| WO2008077810A3 (en) | Spiro-piperidine derivatives | |
| TW200833696A (en) | Spiro-piperidine derivatives | |
| BR112015007991A2 (pt) | derivados de etinila como moduladores da atividade do receptor de mglur5 | |
| ATE295845T1 (de) | Prucaloprid-n-oxid | |
| HRP20130983T1 (hr) | Derivati arilciklopropilacetamida, korisni kao aktivatori glukokinaze | |
| HRP20120343T1 (hr) | Derivati diarilmetil piperazina, njihovi pripravci i njihova uporaba |